Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis
Background This study aims to compare the effectiveness and safety of nirmatrelvir/ritonavir
(Paxlovid) and sotrovimab for coronavirus disease 2019 (COVID-19). Methods A search was …
(Paxlovid) and sotrovimab for coronavirus disease 2019 (COVID-19). Methods A search was …
Early pandemic in-hospital outcomes and mortality risk factors in COVID-19 solid organ transplant patients
Background Solid organ transplant (SOT) recipients with COVID-19 have a higher risk of
mortality than those without COVID-19. However, it is unclear how SOT patient outcomes …
mortality than those without COVID-19. However, it is unclear how SOT patient outcomes …
Semi-Supervised Dual-Manifold Regularized Fuzzy Broad Learning for ICU Admission Prediction in Post-COVID Transplant Recipients
X Zhang, À Nebot - … Conference on Fuzzy Systems (FUZZ-IEEE), 2024 - ieeexplore.ieee.org
This paper introduces a novel semi-supervised Dual-Manifold Regularized Fuzzy Broad
Learning System (DMR-FBLS) designed for predicting intensive care unit (ICU) admissions …
Learning System (DMR-FBLS) designed for predicting intensive care unit (ICU) admissions …
Generation of CRISPR-Cas9-edited Tacrolimus-resistant SARS-CoV-2-specific T-cells for adoptive cell therapy in transplant patients
L Peter - 2024 - refubium.fu-berlin.de
Solid organ transplant recipients require permanent immunosuppression to prevent graft
rejection. This impairs their immune response to infections and vaccines, putting transplant …
rejection. This impairs their immune response to infections and vaccines, putting transplant …
[PDF][PDF] ПРЕДИКТОРЫ НЕБЛАГОПРИЯТНОГО ИСХОДА КОРОНАВИРУСНОЙ ИНФЕКЦИИ, ВЫЗВАННОЙ ВИРУСОМ SARS-CoV-2, У ПАЦИЕНТОВ НА …
АВИ ШУМАКОВА, СВ КОНДРАШКИНА - transpl.ru
Пандемия коронавирусной инфекции, вызванной вирусом SARS-CoV-2, остаётся
значимой проблемой для общественного здравоохранения. Тяжелые формы …
значимой проблемой для общественного здравоохранения. Тяжелые формы …
[HTML][HTML] Development of donor specific antibodies after SARS-CoV-2 vaccination: What do we know so far?
Vaccination against Coronavirus disease-19 (COVID-19) was pivotal to limit spread,
morbidity and mortality. Our aim is to find out whether vaccines against COVID-19 lead to an …
morbidity and mortality. Our aim is to find out whether vaccines against COVID-19 lead to an …